Redesign science

Computational drug discovery company focusing on lead discovery against challenging and emerging drug targets, including protein-protein interactions. Redesign Science utilizes physics-based atomic-level molecular dynamics to simulate biomolecular systems from first principles, aiming to enhance the accuracy and efficiency of drug discovery processes. The company's services are primarily targeted at pharmaceutical and biotechnology firms seeking advanced computational methods to identify and develop new therapeutic compounds.

Redesign science was discovered on July 31st 2021 and it currently has a search volume of 90 with a growth of +456%.